Artificial Intelligence (AI) in Medicine

Abstract

This session will explore the implications of the AI Act for the healthcare sector, discuss global regulatory trends, and provide practical guidance for pharmaceutical companies and healthcare providers. Gain insights from experts and understand how to navigate the evolving landscape of AI regulation to ensure compliance and drive innovation in digital health from a expert organization leading the compliance of AI as Medical Device in the EU and US. This session will cover the following key points:

- Overview of the AI Act: Key provisions and requirements relevant to healthcare and pharmaceuticals.

- Global AI Regulatory Landscape: Comparison with international AI regulations and standards.

- Impact on Healthcare: How the AI Act influences industry usage, data privacy, and ethical considerations.

- Implementation Roadmap: Industry guidance for integrating AI within their business activities.

- Case Studies: Real-world examples of AI implementation in healthcare and its regulatory implications.

- Q&A Session: Engage with experts to address specific concerns and questions.

Biography

Miguel Amador is the Chief Innovation Officer at Complear, paving the way for regulatory compliance of medical device software worldwide with digital tools and AI. An expert in digital health and AI and deep tech investor. Miguel is also an expert working as an evaluator and mentor with the European Innovation Council and the European Research Council in the field of healthcare. He has a background in biomedical engineering from Técnico Lisboa and a research focus on risk governance and public policy of health innovation at MIT Portugal program, had been awarded a Fulbright Fellowship to the MIT, USA.